4.2 Review

Gastrointestinal Brachytherapy

Related references

Note: Only part of the references are listed.
Review Oncology

Anal cancer brachytherapy: From radon seeds to interstitial Papillon technique in a century. What does the future hold?

Primoz Petric et al.

Summary: Evidence shows that combining 2D-3D external beam radiotherapy (EBRT) +/- chemotherapy with 2D brachytherapy (BT) for anal cancer leads to better outcomes compared to chemo-EBRT alone. Further advancements in intensity modulated EBRT and MRI-guided adaptive BT are expected to improve results. However, the use of BT as a therapeutic option is not discussed in international guidelines and remains limited due to various factors such as specialized skills, complexity, equipment, cost, and reimbursement policies. This article argues that the role of BT in chemoradiation should be reconsidered and highlights its potential in the context of combined intensity modulated EBRT, chemotherapy, and MRI-guided adaptive BT.

RADIOTHERAPY AND ONCOLOGY (2022)

Review Oncology

Contact X-ray brachytherapy for rectal cancer: Past, present, and future

J-P Gerard et al.

Summary: Contact X-ray brachytherapy of 50 kV has been shown to be efficient and safe for achieving long term local control and organ preservation in cT1 and early cT2-3 rectal cancers. The use of this treatment strategy is expected to be further supported and expanded in future trials.

CANCER RADIOTHERAPIE (2021)

Article Oncology

Interstitial High-Dose-Rate Brachytherapy of Liver Metastases in Oligometastatic Patients

Franziska Walter et al.

Summary: Local ablative treatments, including interstitial brachytherapy (iBT), have shown promise in treating patients with oligometastatic liver disease. The study found that iBT is safe and effective, with good local control rates and low toxicity, especially in patients with smaller liver metastases.

CANCERS (2021)

Article Cardiac & Cardiovascular Systems

Radioablation by Image-Guided (HDR) Brachytherapy and Transarterial Chemoembolization in Hepatocellular Carcinoma: A Randomized Phase II Trial

Konrad Mohnike et al.

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2019)

Article Oncology

High-dose-rate pre-operative endorectal brachytherapy for patients with rectal cancer

Te Vuong et al.

JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2015)

Article Oncology

Long-Term Results of a Randomized Trial in Locally Advanced Rectal Cancer: No Benefit From Adding a Brachytherapy Boost

Ane L. Appelt et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)

Article Oncology

Preoperative chemoradiation of locally advanced T3 rectal cancer combined with an endorectal boost

A Jakobsen et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)